Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

Ryerson University

$119,950.00

Optimization of a device for the storage, mixing and delivery of sterilized bone adhesive

EF 2018-19

Résumé
The development of a beta-prototype device for the sterilized storage, mixing and controlled delivery of a bioadhesive.*In 2015, there were 47,000 wrist fractures reported in Canada. A 2010 estimate for the total annual cost of treating wrist fractures was $104M. One method postulated for improving surgical outcomes in this space is percutaneous fracture fixation.*A consortia of engineers and clinicians, led by Principal Applicant Towler, are developing proprietary glass polyalkenoate cements (GPCs) through a NSERC/CIHR CHRP grant secured in 2016. These materials are injectable, adhesive to bone and can be formulated to be both antibacterial and osteogenic at the fracture site. However, of equal importance to the bioadhesive is the development and optimization of a '3-in-1' procedural device which facilitates: 1. the storage of the bioadhesive precursors, 2. their uniform mixing and 3. Their controlled delivery by surgeons to the fracture site. Collectively, the solution (the delivery device and the bioadhesive, henceforth known as the 'Kit'), will provide standardization of the application process, reducing risks associated with improper handling of the bioadhesive in operating rooms which directly translates to cost saving outcomes for the Canadian healthcare system.*The team, led by Towler, assisted by PDF Alhalawani and with collaborators from the engineering (Protodev Canada) and clinical fields (Drs. Zalzal and Safir), will amend an alpha prototype delivery device, within the space covered by Towler's provisional patent. The project will yield a beta device with improved durability, reduced complexity and increased capacity, which will expand its functionality. Although the intended use of*the device is to store, mix and deliver the bioadhesive to surgical sites, the steps being taken are not clinical in nature, but fundamental engineering in their approach which may result in a device that leaves the clinic for exploitation in fields such as the delivery of glues and epoxies for coating, insulation and sealing applications.*
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
523282-2018
Name nom
Towler, Mark
Department département
Mechanical and Industrial Engineering
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
119950
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
508
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Polymers, rubber and plastics
Area of application fr
Polymères, caoutchouc et plastiques
Research subject code
2002
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Materials processing
Research subject fr
Transformation des matériaux
Partie
1
Nb partie
1
Application title
Optimization of a device for the storage, mixing and delivery of sterilized bone adhesive
Keyword
NSERC
Application summary
The development of a beta-prototype device for the sterilized storage, mixing and controlled delivery of a bioadhesive.*In 2015, there were 47,000 wrist fractures reported in Canada. A 2010 estimate for the total annual cost of treating wrist fractures was $104M. One method postulated for improving surgical outcomes in this space is percutaneous fracture fixation.*A consortia of engineers and clinicians, led by Principal Applicant Towler, are developing proprietary glass polyalkenoate cements (GPCs) through a NSERC/CIHR CHRP grant secured in 2016. These materials are injectable, adhesive to bone and can be formulated to be both antibacterial and osteogenic at the fracture site. However, of equal importance to the bioadhesive is the development and optimization of a '3-in-1' procedural device which facilitates: 1. the storage of the bioadhesive precursors, 2. their uniform mixing and 3. Their controlled delivery by surgeons to the fracture site. Collectively, the solution (the delivery device and the bioadhesive, henceforth known as the 'Kit'), will provide standardization of the application process, reducing risks associated with improper handling of the bioadhesive in operating rooms which directly translates to cost saving outcomes for the Canadian healthcare system.*The team, led by Towler, assisted by PDF Alhalawani and with collaborators from the engineering (Protodev Canada) and clinical fields (Drs. Zalzal and Safir), will amend an alpha prototype delivery device, within the space covered by Towler's provisional patent. The project will yield a beta device with improved durability, reduced complexity and increased capacity, which will expand its functionality. Although the intended use of*the device is to store, mix and deliver the bioadhesive to surgical sites, the steps being taken are not clinical in nature, but fundamental engineering in their approach which may result in a device that leaves the clinic for exploitation in fields such as the delivery of glues and epoxies for coating, insulation and sealing applications.*